Y0000138
Flubendazol
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 31430-15-6
Synonym(S): Flumoxanal, Methyl [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | Y0000138-25-MG | In Stock | ₹ 14,072.50 |
Y0000138 - 25 MG
In Stock
Quantity
1
Base Price: ₹ 14,072.50
GST (18%): ₹ 2,533.05
Total Price: ₹ 16,605.55
grade
pharmaceutical primary standard
API family
flubendazole
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccc(F)cc3
InChI
1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
InChI key
CPEUVMUXAHMANV-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Flubendazole for system suitability European Pharmacopoeia (EP) Reference Standard | 31430-15-6 | MFCD00871999 | | Sigma Aldrich Fine Chemicals Biosciences | ₹ 23,582.90 | |
 | VETRANAL™ Flubendazol, MilliporeSigma™ Supelco™ | MilliporeSigma Supelco | ₹ 21,390.00 | |
 | eMolecules Medchem Express / Flubendazole / 100mg / 446272449 / HY-B0294 / / 31430-15-6 / [null] / 313.288 / C16H12FN3O3 | eMolecules | ₹ 9,067.65 | |
 | Sigma Aldrich Fine Chemicals Biosciences Flubendazol European Pharmacopoeia (EP) Reference StandardPurity: | MW: 313.28 | 31430-15-6 | MFCD00871999 | 0 | Sigma Aldrich Fine Chemicals Biosciences | ₹ 16,036.51 | |
 | Flubendazole for system suitability | Sigma Aldrich | ₹ 16,107.60 | |
| | Flubendazol | Supelco | ₹ 19,506.65 | |
 | 31430-15-6 | methyl N-{5-[(4-fluorophenyl)carbonyl]-1H-1,3-benzodiazol-2-yl}carbamate | A2B Chem | ₹ 427.80 - ₹ 23,101.20 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Flubendazol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: flubendazole
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccc(F)cc3
InChI: 1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
InChI key: CPEUVMUXAHMANV-UHFFFAOYSA-N
grade:
pharmaceutical primary standard
API family:
flubendazole
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccc(F)cc3
InChI:
1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
InChI key:
CPEUVMUXAHMANV-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: flubendazole
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccc(F)cc3
InChI: 1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
InChI key: CPEUVMUXAHMANV-UHFFFAOYSA-N
grade:
pharmaceutical primary standard
API family:
flubendazole
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccc(F)cc3
InChI:
1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
InChI key:
CPEUVMUXAHMANV-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: ioxaglic acid
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: __
InChI: 1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43)
InChI key: TYYBFXNZMFNZJT-UHFFFAOYSA-N
grade:
pharmaceutical primary standard
API family:
ioxaglic acid
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
__
InChI:
1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43)
InChI key:
TYYBFXNZMFNZJT-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: rifabutin
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: __
InChI: 1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
InChI key: ATEBXHFBFRCZMA-VXTBVIBXSA-N
grade:
pharmaceutical primary standard
API family:
rifabutin
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
__
InChI:
1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
InChI key:
ATEBXHFBFRCZMA-VXTBVIBXSA-N